Rituximab in severe skin diseases: target, disease, and dose

New clinical indications for rituximab seem to appear every day. This review will trace the use of this monoclonal antibody from lymphoid malignancy, to classic autoimmune disease, and specifically severe autoimmune skin diseases. The history leading to different dosing schema with associated pharma...

Descripción completa

Detalles Bibliográficos
Autores principales: Bennett, Daniel D, Ohanian, Maro, Cable, Christian T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262375/
https://www.ncbi.nlm.nih.gov/pubmed/22291497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262375/
https://www.ncbi.nlm.nih.gov/pubmed/22291497

Ejemplares similares